Location History:
- Heidleberg, DE (1981)
- Heidelberg, DE (2005 - 2014)
Company Filing History:
3 out of 155 
1 out of 84 
1 out of 1 
Years Active: 1981-2014
Title: Norbert Fusenig: Innovator in Biomedical Research
Introduction
Norbert Fusenig is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of innovative solutions for skin-related therapies. With a total of 4 patents, his work has had a substantial impact on both pharmaceutical and cosmetic industries.
Latest Patents
Fusenig's latest patents include groundbreaking inventions such as a scaffold-based organotypic culture for the long-term cultivation of human epidermal stem cells. This invention focuses on improving the stability of epidermal cell cultures, which are essential for screening pharmaceutical and cosmetic agents. The skin equivalent he developed comprises a dermal equivalent made of nonwoven viscose fabric and fibroblasts, along with keratinocytes. Another notable patent involves biomaterials based on hyaluronic acid for anti-angiogenic therapy in tumor treatment. This invention aims to suppress the angiogenic process associated with tumor proliferation, showcasing Fusenig's commitment to advancing medical-surgical applications.
Career Highlights
Throughout his career, Norbert Fusenig has worked with esteemed organizations such as the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Fidia Farmaceutici S.p.a. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research and treatment.
Collaborations
Fusenig has collaborated with notable colleagues, including Wolfgang Thon and Hans-Jürgen Stark. These partnerships have further enriched his research and innovation efforts, leading to the development of impactful biomedical solutions.
Conclusion
Norbert Fusenig's contributions to biomedical research and innovation are noteworthy. His patents reflect a deep commitment to improving health outcomes through scientific advancements. His work continues to inspire future innovations in the field.